High-dose Erythropoietin for Asphyxia and Encephalopathy

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2016
Hypoxic-ischemic encephalopathy (HIE) occurs when a baby gets reduced blood flow and oxygen to the brain near the time of birth. This results in death or neurologic disabilities including cerebral palsy and cognitive impairment in up to half of affected infants. This clinical trial will determine if the drug erythropoietin (Epo) added to hypothermia (usual therapy) will improve outcomes for infants suffering from HIE.
Epistemonikos ID: 4242acef83236f5a55e01a33bdf7d89dc28af4f3
First added on: Jan 28, 2022